Multivariable-adjusted HRs were calculated using Cox proportional regression models.<h4>Results</h4>There was no significant association between Lp(a) concentrations or apo(a) isoform sizes and the risk of recurrent stroke, the primary outcome of SPARCL, or cerebrovascular events in patients randomized to atorvastatin or placebo. Here, LPA is linked to stroke disorder.